News
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results